Elekta AB ADR | Income Statement

Fiscal year is May-April. All values SEK Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
10,694
10,839
11,221
10,704
11,332
13,555
Cost of Goods Sold (COGS) incl. D&A
6,389
6,964
7,174
6,892
7,207
7,871
Gross Income
4,305
3,875
4,047
3,812
4,125
5,684
SG&A Expense
2,498
2,904
2,861
2,496
2,628
3,931
EBIT
1,807
971
1,186
1,316
1,497
1,753
Unusual Expense
161
3
598
518
14
-
Non Operating Income/Expense
80
18
162
201
44
55
Interest Expense
231
259
285
271
225
186
Pretax Income
1,517
716
178
357
1,368
1,577
Income Tax
350
158
44
214
276
382
Equity in Affiliates
15
-
11
17
7
3
Consolidated Net Income
1,152
558
145
126
1,099
1,198
Net Income
1,148
552
137
125
1,099
1,198
Net Income After Extraordinaries
1,148
552
137
125
1,099
1,198
Net Income Available to Common
1,148
552
137
125
1,099
1,198
EPS (Basic)
3.01
1.45
0.36
0.33
2.88
3.14
Basic Shares Outstanding
381
381
381
381
382
382
EPS (Diluted)
2.87
1.45
0.36
0.33
2.88
3.14
Diluted Shares Outstanding
401
381
381
381
382
382
EBITDA
2,221
1,483
1,820
1,971
2,172
2,032
Non-Operating Interest Income
22
25
37
31
66
66
Minority Interest Expense
4
6
8
1
-
-

About Elekta AB

View Profile
Address
Kungstensgatan 18
Stockholm SD 103 93
Sweden
Employees -
Website http://www.elekta.com
Updated 07/08/2019
Elekta AB engages in the provision of clinical solutions for the treatment of cancers and brain disorders. Its products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America; Europe.